Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

Steve Beuchaw

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

Voice-of-Customer Research

KOL Identification

Clinical Diagnostics

Infectious Pathogen Diagnostics Technology Commercialization

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

Voice-of-Customer Research

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

Voice-of-Customer Research

Pharma & Biotech

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

Revenue Projection

Precision Medicine is evolving at a rapid pace

Discover how we can help